AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
MINERALIZED BONE LOSS AT DIFFERENT SITES IN DIALYSIS PATIENTS - IMPLICATIONS FOR PREVENTION
Authors: SCHOBER HC HAN ZH FOLDES AJ SHIH MS RAO DS BALENA R PARFITT AM
Citation: Hc. Schober et al., MINERALIZED BONE LOSS AT DIFFERENT SITES IN DIALYSIS PATIENTS - IMPLICATIONS FOR PREVENTION, Journal of the American Society of Nephrology, 9(7), 1998, pp. 1225-1233
A 1-YEAR OPEN-LABEL FOLLOW-UP-STUDY IN 121 POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH CYCLICAL ETIDRONATE
Authors: FOGELMAN I HERD RJMM BLAKE GM BALENA R
Citation: I. Fogelman et al., A 1-YEAR OPEN-LABEL FOLLOW-UP-STUDY IN 121 POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH CYCLICAL ETIDRONATE, Journal of bone and mineral research, 12, 1997, pp. 276-276
BISPHOSPHONATE RISEDRONATE PREVENTS BONE LOSS IN WOMEN WITH ARTIFICIAL MENOPAUSE DUE TO CHEMOTHERAPY OF BREAST-CANCER - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: DELMAS PD BALENA R CONFRAVREUX E HARDOUIN C HARDY P BREMOND A
Citation: Pd. Delmas et al., BISPHOSPHONATE RISEDRONATE PREVENTS BONE LOSS IN WOMEN WITH ARTIFICIAL MENOPAUSE DUE TO CHEMOTHERAPY OF BREAST-CANCER - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Journal of clinical oncology, 15(3), 1997, pp. 955-962
PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP)
Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C DELMAS PD BALENA R
Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP), The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2784-2791
PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP) (VOL 82, PG 2784, 1997)
Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C DELMAS PD BALENA R
Citation: Pj. Meunier et al., PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS WITH CYCLICAL ETIDRONATETHERAPY (A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY AND 1-YEAR FOLLOW-UP) (VOL 82, PG 2784, 1997), The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3740-3740
THE PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY CYCLICAL ETIDRONATE THERAPY - A 2-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: HERD RJM BALENA R BLAKE GM RYAN PJ FOGELMAN I
Citation: Rjm. Herd et al., THE PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY CYCLICAL ETIDRONATE THERAPY - A 2-YEAR, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, The American journal of medicine, 103(2), 1997, pp. 92-99
COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES
Authors: MASARACHIA P WEINREB M BALENA R RODAN GA
Citation: P. Masarachia et al., COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES, Bone, 19(3), 1996, pp. 281-290
EFFECTS OF CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION OF BONE LOSSIN EARLY POSTMENOPAUSAL WOMEN
Authors: HEATH DA BULLIVANT BG WEBBER D PACK S BALENA R
Citation: Da. Heath et al., EFFECTS OF CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION OF BONE LOSSIN EARLY POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 11, 1996, pp. 644-644
LONG-TERM SAFETY OF THE AMINOBISPHOSPHONATE ALENDRONATE IN ADULT DOGS.2. HISTOMORPHOMETRIC ANALYSIS OF THE L5 VERTEBRAE
Authors: BALENA R MARKATOS A SEEDOR JG GENTILE M STARK C PETER CP RODAN GA
Citation: R. Balena et al., LONG-TERM SAFETY OF THE AMINOBISPHOSPHONATE ALENDRONATE IN ADULT DOGS.2. HISTOMORPHOMETRIC ANALYSIS OF THE L5 VERTEBRAE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 277-283
INTERLEUKIN-1-BETA GENE DELETION (KNOCKOUT) DOES NOT REDUCE BONE LOSSIN OVARIECTOMIZED MICE
Authors: GENTILE M BALENA R CHEN H RODAN GA
Citation: M. Gentile et al., INTERLEUKIN-1-BETA GENE DELETION (KNOCKOUT) DOES NOT REDUCE BONE LOSSIN OVARIECTOMIZED MICE, Journal of bone and mineral research, 10, 1995, pp. 242-242
COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES
Authors: MASARACHIA P WEINREB M BALENA R RODAN GA
Citation: P. Masarachia et al., COMPARISON OF THE DISTRIBUTION OF H-3 ALENDRONATE AND H-3 ETIDRONATE IN RAT AND MOUSE BONES, Journal of bone and mineral research, 10, 1995, pp. 250-250
CYCLICAL ETIDRONATE THERAPY PREVENTS BONE LOSS IN THE EARLY POSTMENOPAUSAL PERIOD
Authors: MEUNIER PJ CONFAVREUX E TUPINON I HARDOUIN C LOCKWOOD C BALENA R DELMAS PD
Citation: Pj. Meunier et al., CYCLICAL ETIDRONATE THERAPY PREVENTS BONE LOSS IN THE EARLY POSTMENOPAUSAL PERIOD, Journal of bone and mineral research, 10, 1995, pp. 357-357
EFFECT OF RISEDRONATE ON COLLAGEN CROSS-LINKS IN POSTMENOPAUSAL OSTEOPOROSIS
Authors: ZEGELS B BALENA R EASTELL R RUSSELL RGG PACK SE REGINSTER JY
Citation: B. Zegels et al., EFFECT OF RISEDRONATE ON COLLAGEN CROSS-LINKS IN POSTMENOPAUSAL OSTEOPOROSIS, Journal of bone and mineral research, 10, 1995, pp. 455-455
DIFFERENTIATING BETWEEN ORCHIECTOMIZED RATS AND CONTROLS USING MEASUREMENTS OF TRABECULAR BONE-DENSITY - A COMPARISON AMONG DXA, HISTOMORPHOMETRY, AND PERIPHERAL QUANTITATIVE COMPUTERIZED-TOMOGRAPHY
Authors: ROSEN HN TOLLIN S BALENA R MIDDLEBROOKS VL BEAMER WG DONOHUE LR ROSEN C TURNER A HOLICK M GREENSPAN SL
Citation: Hn. Rosen et al., DIFFERENTIATING BETWEEN ORCHIECTOMIZED RATS AND CONTROLS USING MEASUREMENTS OF TRABECULAR BONE-DENSITY - A COMPARISON AMONG DXA, HISTOMORPHOMETRY, AND PERIPHERAL QUANTITATIVE COMPUTERIZED-TOMOGRAPHY, Calcified tissue international, 57(1), 1995, pp. 35-39
COMPARISON OF ALENDRONATE AND SODIUM-FLUORIDE EFFECTS ON CANCELLOUS AND CORTICAL BONE IN MINIPIGS - A ONE-YEAR STUDY
Authors: LAFAGE MH BALENA R BATTLE MA SHEA M SEEDOR JG KLEIN H HAYES WC RODAN GA
Citation: Mh. Lafage et al., COMPARISON OF ALENDRONATE AND SODIUM-FLUORIDE EFFECTS ON CANCELLOUS AND CORTICAL BONE IN MINIPIGS - A ONE-YEAR STUDY, The Journal of clinical investigation, 95(5), 1995, pp. 2127-2133
BONE-DENSITY IS NORMAL IN MALE-RATS TREATED WITH FINASTERIDE
Authors: ROSEN HN TOLLIN S BALENA R MIDDLEBROOKS VL MOSES AC YAMAMOTO M ZEIND AJ GREENSPAN SL
Citation: Hn. Rosen et al., BONE-DENSITY IS NORMAL IN MALE-RATS TREATED WITH FINASTERIDE, Endocrinology, 136(4), 1995, pp. 1381-1387
ENDOGENOUS CALCITONIN ATTENUATES PARATHYROID HORMONE-INDUCED CANCELLOUS BONE LOSS IN THE RAT
Authors: YAMAMOTO M SEEDOR JG RODAN GA BALENA R
Citation: M. Yamamoto et al., ENDOGENOUS CALCITONIN ATTENUATES PARATHYROID HORMONE-INDUCED CANCELLOUS BONE LOSS IN THE RAT, Endocrinology, 136(2), 1995, pp. 788-795
INTERLEUKIN-6 DEFICIENT MICE ARE PROTECTED FROM BONE LOSS CAUSED BY ESTROGEN DEPLETION
Authors: POLI V BALENA R FATTORI E MARKATOS A YAMAMOTO M TANAKA H CILIBERTO G RODAN GA COSTANTINI F
Citation: V. Poli et al., INTERLEUKIN-6 DEFICIENT MICE ARE PROTECTED FROM BONE LOSS CAUSED BY ESTROGEN DEPLETION, EMBO journal, 13(5), 1994, pp. 1189-1196
THE AMINOBISPHOSPHONATE ALENDRONATE INHIBITS BONE LOSS INDUCED BY THYROID-HORMONE IN THE RAT COMPARISON BETWEEN EFFECTS ON TIBIAE AND VERTEBRAE
Authors: BALENA R MARKATOS A GENTILE M MASARACHIA P SEEDOR JG RODAN GA YAMAMOTO M
Citation: R. Balena et al., THE AMINOBISPHOSPHONATE ALENDRONATE INHIBITS BONE LOSS INDUCED BY THYROID-HORMONE IN THE RAT COMPARISON BETWEEN EFFECTS ON TIBIAE AND VERTEBRAE, Bone, 14(3), 1993, pp. 499-504
PRECLINICAL PHARMACOLOGY OF ALENDRONATE
Authors: RODAN GA SEEDOR JG BALENA R
Citation: Ga. Rodan et al., PRECLINICAL PHARMACOLOGY OF ALENDRONATE, Osteoporosis international, 3, 1993, pp. 190000007-190000012
EFFECTS OF COMBINED PROSTAGLANDIN AND ALENDRONATE TREATMENT ON THE HISTOMORPHOMETRY AND BIOMECHANICAL PROPERTIES OF BONE IN OVARIECTOMIZED RATS
Authors: LAURITZEN DB BALENA R SHEA M SEEDOR JG MARKATOS A LE HM TOOLAN BC MYERS ER RODAN GA HAYES WC
Citation: Db. Lauritzen et al., EFFECTS OF COMBINED PROSTAGLANDIN AND ALENDRONATE TREATMENT ON THE HISTOMORPHOMETRY AND BIOMECHANICAL PROPERTIES OF BONE IN OVARIECTOMIZED RATS, Journal of bone and mineral research, 8(7), 1993, pp. 871-879
DIRECT DEMONSTRATION OF INHIBITORY EFFECT OF ECHISTATIN ON PTH-INDUCED BONE-RESORPTION IN-VIVO IN MICE
Authors: YAMAMOTO M BALENA R MARKATOS A GENTILE M GARSKY VM RODAN GA
Citation: M. Yamamoto et al., DIRECT DEMONSTRATION OF INHIBITORY EFFECT OF ECHISTATIN ON PTH-INDUCED BONE-RESORPTION IN-VIVO IN MICE, Journal of bone and mineral research, 8, 1993, pp. 190000123-190000123
MICE WITH IL-6 GENE KNOCK-OUT DO NOT LOSE CANCELLOUS BONE AFTER OVARIECTOMY
Authors: BALENA R COSTANTINI F YAMAMOTO M MARKATOS A CORTESE R RODAN GA POLI V
Citation: R. Balena et al., MICE WITH IL-6 GENE KNOCK-OUT DO NOT LOSE CANCELLOUS BONE AFTER OVARIECTOMY, Journal of bone and mineral research, 8, 1993, pp. 190000130-190000130
THE BISPHOSPHONATE ALENDRONATE PRESERVES BOTH THE MECHANICAL-PROPERTIES AND BONE-MINERAL DENSITY IN THE AGING ESTROGEN-DEFICIENT RAT
Authors: GUY JA SHEA M BALENA R SEEDOR JG RODAN G HAYES WC
Citation: Ja. Guy et al., THE BISPHOSPHONATE ALENDRONATE PRESERVES BOTH THE MECHANICAL-PROPERTIES AND BONE-MINERAL DENSITY IN THE AGING ESTROGEN-DEFICIENT RAT, Journal of bone and mineral research, 8, 1993, pp. 190000134-190000134
ENDOGENOUS CALCITONIN REDUCES PTH-INDUCED BONE-RESORPTION IN RATS
Authors: YAMAMOTO M SEEDOR JG RODAN GA BALENA R
Citation: M. Yamamoto et al., ENDOGENOUS CALCITONIN REDUCES PTH-INDUCED BONE-RESORPTION IN RATS, Journal of bone and mineral research, 8, 1993, pp. 190000191-190000191
Risultati: 1-25 | 26-32